Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ravi K. Amaravadi
Radiation and Dual Checkpoint Blockade Activate Non-Redundant Immune Mechanisms in Cancer
Nature
Multidisciplinary
Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
Nature
Multidisciplinary
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
Cancer Discovery
Oncology
Association of First-In-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma
JAMA Oncology
Cancer Research
Oncology
Long-Term Outcome in BRAFV600E Melanoma Patients Treated With Vemurafenib: Patterns of Disease Progression and Clinical Management of Limited Progression
European Journal of Cancer
Cancer Research
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
Dimeric Quinacrines as Chemical Tools to Identify PPT1, a New Regulator of Autophagy in Cancer Cells
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Autophagy-Induced Tumor Dormancy in Ovarian Cancer
Journal of Clinical Investigation
Medicine
Autophagy Inhibition Enhances Therapy-Induced Apoptosis in a Myc-Induced Model of Lymphoma
Journal of Clinical Investigation
Medicine
